Literature DB >> 16171712

Diagnostic accuracy of myocardial perfusion imaging in a study population without post-test referral bias.

Allan Johansen1, Poul Flemming Høilund-Carlsen, Henrik Wulff Christensen, Werner Vach, Henrik Boel Jørgensen, Annegrete Veje, Torben Haghfelt.   

Abstract

BACKGROUND: Most previous studies on the accuracy of myocardial perfusion imaging (MPI) are hampered by post-test referral bias, in that referral for coronary angiography was influenced by the MPI result. In this way, patients with a normal MPI result less frequently underwent catheterization, a tendency supposed to cause an underestimation of test specificity and an overestimation of test sensitivity. METHODS AND
RESULTS: MPI by use of a gated dual-isotope protocol was undertaken before angiography in 357 patients referred for angiography for suspected stable angina pectoris. The MPI reports were kept secret to prevent post-test referral bias. The MPI study was normal in 215 patients (60%) and showed reversible perfusion abnormalities in 118 (33%) and fixed defects in 24 (7%). Angiography was normal in 231 patients (65%) and revealed 1 or more significant stenoses in 126 (35%). With angiography as the reference, the sensitivity and specificity of MPI for detecting significant coronary artery stenosis were 75% and 79%, respectively.
CONCLUSIONS: In this prospective study without post-test referral bias, we found a lower sensitivity and slightly higher specificity than in studies with post-test referral bias. The imperfect accuracy may reflect differences between anatomic and physiologic imaging.

Entities:  

Mesh:

Year:  2005        PMID: 16171712     DOI: 10.1016/j.nuclcard.2005.04.012

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  47 in total

Review 1.  Contributions of nuclear cardiology to diagnosis and prognosis of patients with coronary artery disease.

Authors:  G A Beller; B L Zaret
Journal:  Circulation       Date:  2000-03-28       Impact factor: 29.690

2.  The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: an observational assessment of the value of precatheterization ischemia. Economics of Noninvasive Diagnosis (END) Multicenter Study Group.

Authors:  L J Shaw; R Hachamovitch; D S Berman; T H Marwick; M S Lauer; G V Heller; A E Iskandrian; K L Kesler; M I Travin; H C Lewin; R C Hendel; S Borges-Neto; D D Miller
Journal:  J Am Coll Cardiol       Date:  1999-03       Impact factor: 24.094

3.  Comparative ability of myocardial perfusion single-photon emission computed tomography to detect coronary artery disease in patients with and without diabetes mellitus.

Authors:  X Kang; D S Berman; H Lewin; R Miranda; J Erel; J D Friedman; A M Amanullah
Journal:  Am Heart J       Date:  1999-05       Impact factor: 4.749

4.  Pharmacologic stress testing for coronary disease diagnosis: A meta-analysis.

Authors:  C Kim; Y S Kwok; P Heagerty; R Redberg
Journal:  Am Heart J       Date:  2001-12       Impact factor: 4.749

5.  Limited incremental diagnostic values of attenuation-noncorrected gating and ungated attenuation correction to rest/stress myocardial perfusion SPECT in patients with an intermediate likelihood of coronary artery disease.

Authors:  D S Lee; Y So; G J Cheon; K M Kim; M M Lee; J K Chung; M C Lee
Journal:  J Nucl Med       Date:  2000-05       Impact factor: 10.057

6.  Interpretive reproducibility of stress Tc-99m sestamibi tomographic myocardial perfusion imaging.

Authors:  R J Golub; A W Ahlberg; J R McClellan; S D Herman; M I Travin; J F Mather; P W Aitken; J I Baron; G V Heller
Journal:  J Nucl Cardiol       Date:  1999 May-Jun       Impact factor: 5.952

7.  Exercise echocardiography or exercise SPECT imaging? A meta-analysis of diagnostic test performance.

Authors:  K E Fleischmann; M G Hunink; K M Kuntz; P S Douglas
Journal:  JAMA       Date:  1998-09-09       Impact factor: 56.272

8.  Value of stress myocardial perfusion single photon emission computed tomography in patients with normal resting electrocardiograms: an evaluation of incremental prognostic value and cost-effectiveness.

Authors:  Rory Hachamovitch; Daniel S Berman; Hosen Kiat; Ishac Cohen; John D Friedman; Leslee J Shaw
Journal:  Circulation       Date:  2002-02-19       Impact factor: 29.690

9.  Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study.

Authors:  D S Berman; H Kiat; J D Friedman; F P Wang; K van Train; L Matzer; J Maddahi; G Germano
Journal:  J Am Coll Cardiol       Date:  1993-11-01       Impact factor: 24.094

10.  Quantitative rotational thallium-201 tomography for identifying and localizing coronary artery disease.

Authors:  E E DePasquale; A C Nody; E G DePuey; E V Garcia; G Pilcher; C Bredlau; G Roubin; A Gober; A Gruentzig; P D'Amato
Journal:  Circulation       Date:  1988-02       Impact factor: 29.690

View more
  11 in total

1.  Patients with adenosine-induced ST-segment depressions and normal myocardial perfusion imaging: cardiac outcomes at 24 months.

Authors:  Jyoti Sharma; Christine Roncari; Kenneth N Giedd; John T Fox; Yumiko Kanei
Journal:  J Nucl Cardiol       Date:  2010-06-10       Impact factor: 5.952

2.  Diagnostic impact of SPECT image display on assessment of obstructive coronary artery disease.

Authors:  Jonathan W Weinsaft; Christopher L Gade; Franklin J Wong; Han W Kim; James K Min; Shant J Manoushagian; Peter M Okin; Massimiliano Szulc
Journal:  J Nucl Cardiol       Date:  2007 Sep-Oct       Impact factor: 5.952

3.  Letter to the editor.

Authors:  Peter G Danias
Journal:  J Nucl Cardiol       Date:  2006 Jan-Feb       Impact factor: 5.952

4.  Angina pectoris: has the cornerstone of symptomatic coronary artery disease been moved?

Authors:  Renee C Hessian; Rob S B Beanlands
Journal:  Can J Cardiol       Date:  2007-06       Impact factor: 5.223

5.  Rationale and design of the Randomized Evaluation of patients with Stable angina Comparing Utilization of noninvasive Examinations (RESCUE) trial.

Authors:  Arthur E Stillman; Constantine Gatsonis; João A C Lima; William C Black; Jean Cormack; Ilana Gareen; Udo Hoffmann; Tao Liu; Kreton Mavromatis; Mitchell D Schnall; James E Udelson; Pamela K Woodard
Journal:  Am Heart J       Date:  2016-06-17       Impact factor: 4.749

6.  Comparison of the diagnostic accuracies of very low stress-dose with standard-dose myocardial perfusion imaging: Automated quantification of one-day, stress-first SPECT using a CZT camera.

Authors:  Tali Sharir; Marina Pinskiy; Abraham Pardes; Arik Rochman; Vitali Prokhorov; Gil Kovalski; Konstantine Merzon; Andrzej Bojko; Boris Brodkin
Journal:  J Nucl Cardiol       Date:  2015-05-27       Impact factor: 5.952

7.  Single photon emission computed tomography for the diagnosis of coronary artery disease: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2010-06-01

8.  High probability of disease in angina pectoris patients: is clinical estimation reliable?

Authors:  Poul F Høilund-Carlsen; Allan Johansen; Werner Vach; Henrik Wulff Christensen; Mette Møldrup; Torben Haghfelt
Journal:  Can J Cardiol       Date:  2007-06       Impact factor: 5.223

9.  Hybrid CT angiography and quantitative 15O-water PET for assessment of coronary artery disease: comparison with quantitative coronary angiography.

Authors:  Anders Thomassen; Henrik Petersen; Axel C P Diederichsen; Hans Mickley; Lisette O Jensen; Allan Johansen; Oke Gerke; Poul-Erik Braad; Per Thayssen; Mette M Høilund-Carlsen; Werner Vach; Juhani Knuuti; Poul F Høilund-Carlsen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-08-28       Impact factor: 9.236

Review 10.  Diagnostic performance of stress myocardial perfusion imaging for coronary artery disease: a systematic review and meta-analysis.

Authors:  Marcus C de Jong; Tessa S S Genders; Robert-Jan van Geuns; Adriaan Moelker; M G Myriam Hunink
Journal:  Eur Radiol       Date:  2012-04-19       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.